Liliana Vasquez1, Essy Maradiegue2, Ninoska Rojas3, Jacqueline Montoya2, Arturo Zapata2, Cecilia Ugaz2, Claudia Pascual4, Carlos Santillán5, Antonio Wachtel6, Edinho Celis7, Hernan Bernedo8, Jonathan Rossi9, Lily Saldaña10, Rosdali Diaz2, Roxana Morales2, Vivian Perez1, Monika L Metzger11, Silvana Luciani12. 1. Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Lima, Peru. 2. Department of Pediatrics, National Institute of Neoplastic Diseases, Lima, Peru. 3. Pediatric Hematology Unit, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru. 4. Pediatric Oncology Unit, Hospital Nacional Guillermo Almenara, Lima, Peru. 5. Department of Epidemiology, National Institute of Children, San Borja, Lima, Peru. 6. Pediatric Oncology Unit, Clinica Angloamericana, Lima, Peru. 7. Department of Nursing, National Institute of Neoplastic Diseases, Lima, Peru. 8. Department of Psychology, National Institute of Neoplastic Diseases, Lima, Peru. 9. Executive Director, Ronald McDonald Association in Peru, Lima, Peru. 10. Department of Surgery, National Institute of Children, San Borja, Lima, Peru. 11. Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN. 12. Unit of Noncommunicable Diseases, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC.
The burden of childhood illnesses has dramatically shifted from communicable to noncommunicable diseases in Peru, with a total estimated population of 32.5 million inhabitants, where cancer is estimated to develop in at least 1800 children and adolescents (0-19 years of age) each year.[1] Up to 70% will present with advanced disease, often metastatic, due to delayed diagnoses. Consequently, nearly half of these patients die.[2] In 2018, the WHO, together with St Jude Children's Research Hospital (St Jude) and the International Society of Pediatric Oncology, launched the Global Initiative for Childhood Cancer (GICC) with the aim to achieve at least a 60% global survival rate for children with cancer by 2030, and, together with the Pan American Health Organization (PAHO), Peru was designated as the first index country for the Region of the Americas.[3]The first steps to improve the care of Peruvian children with cancer were taken in 2016 when Peruvian experts in childhood cancer reviewed the rates of treatment abandonment and delayed diagnoses, and described the poor conditions of care for children with cancer nationwide.[2,4,5] Subsequently, in January 2017, Peruvian pediatric hematologists and oncologists jointly formed the national association for Hemato-Oncología Pediátrica del Peru (HOPPE) to improve conditions encountered by children with cancer through pediatric cancer training and research establishing a plan of action in the short and medium term.In June 2019, PAHO, St Jude, and the Ministry of Health of Peru convened the leading national stakeholders to launch the GICC in Lima. High-level authorities of the state ministries, social security of Peru (EsSalud), national hospitals, academic societies, international partners, and nonprofit organizations contributed to the GICC. Multidisciplinary GICC members formed 10 general working groups (ie, early diagnosis, abandonment, health services, professional education, registry, nursing, psychosocial, infection control, oncologic surgery, and palliative care) and three clinical groups (leukemia, retinoblastoma, and brain tumors, which are three of the six priority malignancies targeted by the WHO GICC to start with) assigned to develop clinical practice guidelines and strategic activities.[6] These working groups generated two official documents approved by the Ministry of Health that have become the cornerstone for childhood cancer care in Peru: the National Health Directive for Early Detection of Cancer in Children and Adolescents and the National Health Directive for the organization of pediatric hematology and oncology services (Fig 1).[7,8]
FIG 1
Milestones of the WHO Global Initiative for Childhood Cancer in Peru. HOPPE, Hemato-Oncología Pediátrica del Peru; GICC, Global Initiative for Childhood Cancer.
Milestones of the WHO Global Initiative for Childhood Cancer in Peru. HOPPE, Hemato-Oncología Pediátrica del Peru; GICC, Global Initiative for Childhood Cancer.Despite these advances, the COVID-19 pandemic has posed significant challenges to sustain the working groups and their activities, but it has also created an opportunity to develop legislation for childhood cancer services. During the COVID-19 pandemic, a survey published by the PAHO and Latin American Society for Pediatric Oncology described the experiences and opinions of childhood cancer specialists from cancer centers throughout Latin America, including Peru. The survey revealed that many services (30%-80%) such as radiotherapy and surgeries were suspended because of the pandemic. Moreover, potentially harmful chemotherapy modifications (35%) were implemented because of difficulties in acquiring medications.[9] Nevertheless, the pandemic increased the visibility of the disparity of childhood cancer deaths in Peru, leading the Peruvian legislature to propose the Childhood Cancer Law in April 2020. On September 2, 2020, President Martin Vizcarra and the Peruvian Parliament enacted the Childhood Cancer Law.[10] This represents an important step for the country, recognizing for the first time the importance of cancer in children as a public health priority in Peru.The Childhood Cancer Law has three primary objectives: (1) universal health coverage for early diagnoses and cancer-related treatments for all children and adolescents, (2) paid parental leave for caregivers of children and adolescents with cancer (a bonus equivalent of two minimum-wage salaries is to be granted to unemployed parents) while their child is hospitalized for treatment, and (3) creation of the National Program for Cancer in Children and Adolescents and a national pediatric cancer registry.[5]During the Childhood Cancer Law proposal process, a social movement called the Colectivo Cancer Infantil YA or Childhood Cancer Law NOW was born. This movement was championed chiefly by pediatric oncologists and parents of children with cancer. Among the achievements of the movement was the formation of a cohesive group of health professionals, volunteers, and parents (up to 150). This group harnessed the power of social networks, newspapers, television, radio, and other media to disseminate their message. PAHO has given its full support and provided advocacy for this purpose.[11] Finally, several stakeholders fully supported the Childhood Cancer Law through written and/or public statements. These stakeholders included the state ministries, EsSalud, physicians, politicians, foundations, and international partners (primarily St Jude and the Latin American Society for Pediatric Oncology).The estimated impact of the law is vast. It aims to save at least 650 lives per year, summing up to 169,000 healthy life years for children who receive successful treatment and survive to adulthood in Peru, and to prevent avoidable suffering among children and their families. Therefore, the Childhood Cancer Law will have great impact in the fight against childhood cancer in Peru, despite a global pandemic. This childhood cancer law is an example of successful collaboration of different stakeholders and can serve as a model for other countries as they become part of the GICC.
Authors: Liliana Vasquez; Jose Silva; Sharon Chavez; Arturo Zapata; Rosdali Diaz; Fanny Tarrillo; Ivan Maza; Luis Sialer; Juan García Journal: Pediatr Blood Cancer Date: 2020-01-11 Impact factor: 3.167
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702